We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTSH icon
326
Cognizant
CTSH
$26B
$5.91M 0.04%
93,202
-1,194,313
-93% -$78.4M
USB icon
327
US Bancorp
USB
$99.6B
$5.88M 0.04%
112,243
-15,530
-12% -$800K
SGEN
328
DELISTED
Seagen Inc. Common Stock
SGEN
$5.84M 0.04%
+84,316
New +$5.9M
XIFR
329
XPLR Infrastructure LP
XIFR
$1.08B
$5.81M 0.04%
+120,484
New +$5.59M
FFIV icon
330
F5
FFIV
$22.7B
$5.78M 0.04%
+39,672
New +$5.94M
GOSS icon
331
Gossamer Bio
GOSS
$87M
$5.77M 0.04%
260,010
-179,451
-41% -$3.43M
BBWI icon
332
Bath & Body Works
BBWI
$4.1B
$5.74M 0.04%
272,219
+107,668
+65% +$2.13M
EC icon
333
Ecopetrol
EC
$34.5B
$5.73M 0.04%
313,148
+307,296
+5,251% +$5.75M
WEX icon
334
WEX
WEX
$6.31B
$5.68M 0.04%
+27,291
New +$5.49M
NTES icon
335
NetEase
NTES
$84.7B
$5.67M 0.04%
+110,865
New +$5.88M
XLRN
336
DELISTED
Acceleron Pharma
XLRN
$5.63M 0.03%
136,932
-246,234
-64% -$10.2M
NVEE
337
DELISTED
NV5 Global
NVEE
$5.61M 0.03%
275,856
+133,140
+93% +$2.38M
M icon
338
Macy's
M
$6.68B
$5.61M 0.03%
261,346
+71,697
+38% +$1.63M
HCA icon
339
HCA Healthcare
HCA
$89.5B
$5.53M 0.03%
+40,885
New +$5.17M
SU icon
340
Suncor Energy
SU
$70.3B
$5.5M 0.03%
175,872
-24,408
-12% -$781K
CCI icon
341
Crown Castle
CCI
$32.2B
$5.49M 0.03%
42,138
-24,642
-37% -$3.17M
MMSI icon
342
Merit Medical Systems
MMSI
$5.32B
$5.49M 0.03%
92,160
+31,183
+51% +$1.79M
FOXA icon
343
Fox Class A
FOXA
$26.9B
$5.46M 0.03%
148,907
-32,152
-18% -$1.18M
ACN icon
344
Accenture
ACN
$108B
$5.42M 0.03%
29,344
-128,779
-81% -$23.1M
CNI icon
345
Canadian National Railway
CNI
$76.6B
$5.39M 0.03%
58,100
+42,500
+272% +$3.9M
NOW icon
346
ServiceNow
NOW
$129B
$5.34M 0.03%
97,160
-42,755
-31% -$2.25M
K
347
DELISTED
Kellanova
K
$5.28M 0.03%
104,976
+99,970
+1,997% +$5.31M
BXMT icon
348
Blackstone Mortgage Trust
BXMT
$2.38B
$5.26M 0.03%
147,785
+146,185
+9,137% +$5.2M
AVYA
349
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$5.23M 0.03%
439,100
+67,598
+18% +$1.03M
T icon
350
AT&T
T
$163B
$5.23M 0.03%
206,596
+119,354
+137% +$2.86M
12 13
14
15 16

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.